Lab Director managing Clinical In vitro Diagnostic (CIVD) and Laboratory Developed tests (LBT) developed by Labcorp Manage a site consisting of 300+ employees engaging in routine clinical diagnostic testing ensuring fidelity, accuracy and delivery of results to clinicians around the world Ensure diagnostic testing and laboratory comply with CLIA/CAP and FDA guidelines including overseeing audits Lead Esoterix-Labcorp discovery group to develop novel diagnostic tests for FDA approval

I lead the Molecular Biology Dept. comprised of 10-12 Sr./Jr. scientists to advance Discovery and Pre-clinical programs to evaluate small molecule technology as treatment for developmental/inflammatory/metabolic diseases caused by genetic and/or epigenetic defects. Served as point of contact for department in cross-functional meetings to coordinate early stage to IND drug discovery strategies. Support Legal/Clinical Teams with technical support for Intellectual Property, IND, and regulatory applications (CLIA, CAP, EMA, FDA, IHC etc.) Coordinate assay design and data analysis and presentation across multiple disease programs. Establish collaborations with Key Opinion Leaders, CRO's, research institutions and advocacy groups.

I managed a team of scientists aimed at developing pharmaceutical against rare genetic diseases

I served as lead scientist for the Research Division of early-stage startup fetal diagnostics company. I established a program to monitor women's reproductive health. • Developed a high-throughput-single-cell platform to isolate and profile genetic/epigenetic/transcriptomic features in low frequency cellular populations present in mucosal samples that predict patient risk for cervical/ovarian cancer and pre-eclampsia. • Managed group of 2-3 scientists and served as point of contact with Sr. Leadership on deliverables, status updates and milestones. • Served as Principal Investigator on NIH SBIR Phase I/II grant.

Principal Investigator, Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA I investigated how early life events influence later life susceptibility to disease leading to the identification of a unique developmental window during gestation that dictates the severity of host immune pathology in the context of IBD, asthma and allergy. • Served as Principal Investigator on NIH funded grants. • Managed a small group of technicians and graduate candidates. • Primary Inventor on 2 patents to neutralize the effects of specific microbial products that exacerbate intestinal inflammation ( PCT/US2016/061799, PCT/US2018/067189). • Science 2016

I developed a computational platform to identify a novel class of environmental triggers of intestinal inflammation including Inflammatory Bowel Disease and Colorectal Cancer. • Served as Principal Investigator (Young Investigator's Grant, Crohn's & Colitis Foundation of America). • Cell 2018